Insider · CIK 0001459154
Mats Wahlstrom
Files at CHRS (Coherus Oncology, Inc.), TLSI (TriSalus Life Sciences, Inc.). First filing Nov 22, 2024, latest May 28, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TLSI: TriSalus Life Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | CHRSsell Coherus Oncology, Inc. | $74k 99,988 shares | -100% | - | |
| 26Weak | TLSIbuy TriSalus Life Sciences, Inc. | $23k 5,000 shares | +47% | - | |
| 29Weak | TLSIbuy TriSalus Life Sciences, Inc. | $47k 10,727 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 200,945 | Jun 27, 2025 |
| Jun 12, 2025 | CHRS Coherus Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +112,000 | $0.00 | $0 | 112,000 | Jun 13, 2025 |
| May 23, 2025 | CHRS Coherus Oncology, Inc. | SOpen-market sale Common Stockindirect: Leonard Capital, LLC | -99,988 | $0.74 | $74k | 0 | May 28, 2025 |
| Dec 17, 2024 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +25,188 | $3.97 | $100k | 40,915 | Dec 19, 2024 |
| Nov 22, 2024 | TLSI TriSalus Life Sciences, Inc. | POpen-market purchase Common Stock | +5,000 | $4.55 | $23k | 15,727 | Nov 25, 2024 |
| Nov 20, 2024 | TLSI TriSalus Life Sciences, Inc. | POpen-market purchase Common Stock | +2,040 | $4.16 | $8,486 | 2,040 | Nov 22, 2024 |
| Nov 21, 2024 | TLSI TriSalus Life Sciences, Inc. | POpen-market purchase Common Stock | +8,687 | $4.44 | $39k | 10,727 | Nov 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.